Loading clinical trials...
Loading clinical trials...
An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery
TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
San Francisco VA Medical Center
San Francisco, California, United States
Yale-New Haven Hospital
New Haven, Connecticut, United States
Maine Medical Center
Portland, Maine, United States
Montefiore Medical Center
The Bronx, New York, United States
Durham Veterans Affairs Medical Center
Durham, North Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Michael E. DeBakey Veterans Affairs Medical Center
Houston, Texas, United States
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
Royal North Shore Hospital
Sydney, New South Wales, Australia
Start Date
January 20, 2014
Primary Completion Date
April 28, 2017
Completion Date
October 1, 2017
Last Updated
August 15, 2018
5,028
ACTUAL participants
Restrictive Transfusion Strategy
OTHER
Liberal transfusion strategy
OTHER
Lead Sponsor
Unity Health Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions